EMA Updates On Brexit Progress With ‘At-Risk’ Drugs And Staffing Issues
Executive Summary
The European Medicines Agency has given an update on its Brexit preparations, including progress with dealing with “at-risk” medicines, staff retention and recruitment issues, and the resumption of some activities that have been temporarily shelved or cut back.